Study #BS99-094
MEASURING THE SYMPTOM DISTRESS OF CANCER PATIENTS: DEVELOPMENT OF A NEW ASSESSMENT SYSTEM
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in patients due to cancer and its treatment and how the symptoms impact quality of life.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Caregiver;Health Care Provider;Malignant Neoplasm;Physician
Study phase:
Physician name:
Xin Shelley Wang
Department:
Symptom Research
For general questions about clinical trials:
1-844-241-7617
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.